<\/p>\n
Melorise<\/strong> is een meloxicam tablet<\/strong> verkrijgbaar in 7.5 mg and 15 mg<\/strong> strengths. Meloxicam is a preferential COX-2 NSAID<\/strong> with a long half-life (~20 hours) that permits dagelijkse dosering<\/strong>. It is used for osteoarthritis (7.5 mg\/day), rheumatoid arthritis, and ankylosing spondylitis (15 mg\/day), and provides strong anti-inflammatory action with a modestly gentler GI profile than non-selective NSAIDs. Take with food.<\/p>\n<\/div>\n \ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n Melorise<\/strong> is een orale tablet van meloxicam<\/strong>, an NSAID in the oxicam class with preferential activity against COX-2. At therapeutic doses (7.5–15 mg\/day), meloxicam inhibits COX-2 (the inflammation-driving isoform) substantially more than COX-1 (the stomach-protective isoform), giving a modest but real reduction in gastric-ulcer risk compared with classical non-selective NSAIDs like diclofenac, ibuprofen, and naproxen.<\/p>\n Meloxicam has a long plasma half-life of approximately 20 hours, which allows simple dagelijkse dosering<\/strong> and steady 24-hour anti-inflammatory cover — a practical advantage in chronic inflammatory arthritis where adherence matters.<\/p>\n Meloxicam is a preferential COX-2 inhibitor. At therapeutic doses it shows roughly a 10-fold selectivity for COX-2 over COX-1, placing it between the non-selective NSAIDs (ibuprofen, diclofenac, naproxen) and the highly selective coxibs (celecoxib, etoricoxib). Clinical trials and meta-analyses confirm a modest but real reduction in GI ulcer and bleed rate compared with non-selective NSAIDs, while pain-relief efficacy is comparable.<\/p>\n Swallow whole with water. Always take with food. If you miss a dose, take it as soon as you remember unless the next dose is due within 8 hours — then skip.<\/p>\n GI, cardiovascular, and renal safety.<\/strong> Meloxicam carries all the standard NSAID risks (GI ulcer, heart attack, stroke, acute kidney injury, raised blood pressure). Use at the lowest effective dose for the shortest clinically reasonable time. Consider adding a proton pump inhibitor for courses longer than 2–4 weeks. Patients with established cardiovascular disease should discuss with their doctor before starting.<\/p>\n<\/div>\nWaarom bestellen bij MedsBase<\/h3>\n
What Is Melorise Used For?<\/h2>\n
\n
How Does Meloxicam Work?<\/h2>\n
Melorise Dosing<\/h2>\n
\n
Who Should Not Take Melorise?<\/h2>\n
\n
Side Effects of Melorise<\/h2>\n
\n
Melorise vs Other NSAIDs<\/h2>\n